Lipoxin A 4 attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects

British Journal of Pharmacology

Volumn 161, Issue 4, 2010, Pages 911-924

  Conte, F P ^a   Menezes De Lima, O Jr ^a   Verri Jr , W A ^b,c   Cunha, F Q ^c   Penido, C ^a   Henriques, M G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

acetylsalicylic acid; BML 111; BOC 1; ET 1; LXA4; neutrophil; oedema formation

Indexed keywords

ACETYLSALICYLIC ACID; BML 111; CXCL1 CHEMOKINE; ENDOTHELIN; ENDOTHELIN 1; FORMYLPEPTIDE RECEPTOR LIKE 1; LEUKOTRIENE B4; LIPOXIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; EDEMA; LEUKOCYTE ACTIVATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SYNOVIAL FLUID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ASPIRIN; EDEMA; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; KNEE JOINT; LIPOXINS; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; RNA, MESSENGER; ZYMOSAN;

EID: 77957229067     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00950.x     Document Type: Article

References (45)

1. Alexander SPH, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254. (Pubitemid 351415518)
2. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol 164 : 1029 1036. (Pubitemid 30043731)
3. Chiang N, Fierro IM, Gronert K, Serhan CN (2000). Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191 : 1197 1208. (Pubitemid 30207682)
4. Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE et al. (2006). The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58 : 463 487. (Pubitemid 44394909)
5. 4, TNF-, and CXCL-1. J Leukoc Biol 84 : 652 660.
6. Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K et al. (2003). Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17 : 652 659. (Pubitemid 37221150)
7. Elferink JG, de Koster BM (1994). Endothelin-induced activation of neutrophil migration. Biochem Pharmacol 48 : 865 871.
8. 4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med 180 : 311 319.
9. 4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170 : 2688 2694. (Pubitemid 36245662)
10. Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN (1999). Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. Blood 94 : 4132 4142.
11. Filep JG, Khreiss T, Jozsef L (2005). Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction. Prostaglandins Leukot Essent Fatty Acids 73 : 257 262. (Pubitemid 41253484)
12. 4 increases gastric resistance to aspirin-induced damage. Gastroenterology 23 : 1598 1606. (Pubitemid 35231659)
13. Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN (2001). Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol 158 : 3 9. (Pubitemid 32096464)
14. Guerrero AT, Verri WA Jr., Cunha TM, Silva TA, Schivo IR, Dal-Secco D et al. (2008). Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol 83 : 122 130.
15. 4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J Exp Med 189 : 1923 1930. (Pubitemid 29295890)
16. Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST (1999). Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med 30 : 51 60. (Pubitemid 29471517)
17. Harris ED Jr. (1991). Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s. Trans Am Clin Climatol Assoc 102 : 260 268. discussion 268-270.
18. 4 and its receptor in synovitis of patients with rheumatoid arthritis. J Rheumatol 34 : 2144 2153. (Pubitemid 350076871)
19. Henriques MG, Silva PM, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J et al. (1987). Mouse paw oedema. A new model for inflammation. Braz J Med Biol Res 20 : 243 249.
20. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K et al. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86 : 2863 2867. (Pubitemid 19112640)
21. 4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesth Analg 104 : 369 377. (Pubitemid 46146744)
22. Jonsson H, Allen P, Peng SL (2005). Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 11 : 666 671. (Pubitemid 40868308)
23. Kassuya CAL, Rogerio AP, Calixto JB (2008). The role of ETA and ETB receptor antagonists in acute and allergic inflammation in mice. Peptides 29 : 1329 1337.
24. Kraan MC, Haringman JJ, Ahern MJ, Breedveld FC, Smith MD, Tak PP (2000). Quantification of the cell infiltrate in synovial tissue by digital image analysis. Rheumatology (Oxford) 39 : 43 49. (Pubitemid 30095405)
25. Kronke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G et al. (2009). 12/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 183 : 3383 3389.
26. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S, Ciolkiewicz M (2006). A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol 25 : 314 319.
27. 4. FASEB J 13 : 903 911.
28. McMahon B, Godson C (2004). Lipoxins: endogenous regulators of inflammation. Am J Physiol Renal Physiol 286 : F189 F201. (Pubitemid 38141663)
29. Maini RN, Taylor PC, Paleolog E, Charles P, Ballara S, Brennan FM et al. (1999). Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Ann Rheum Dis 58 : I56 I60.
30. Mathis S, Jala VR, Haribabu B (2007). Role of leukotriene B4 receptors in rheumatoid arthritis. Autoimmun Rev 7 : 12 17. (Pubitemid 47633386)
31. Mencarelli M, Pecorelli A, Carbotti P, Valacchi G, Grasso G, Muscettola M (2009). Endothelin receptor A expression in human inflammatory cells. Regul Pept 158 : 1 5.
32. 4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. Prostaglandins Other Lipid Mediat 80 : 123 135.
33. Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA et al. (2001). LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol 25 : 707 716. (Pubitemid 33124687)
34. Penido C, Conte FP, Chagas MS, Rodrigues CA, Pereira JF, Henriques MG (2006). Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan-induced arthritis in mice. Inflamm Res 55 : 457 464. (Pubitemid 44826734)
35. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B et al. (2003). Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171 : 6856 6865. (Pubitemid 37532121)
36. 4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol 179 : 8533 8543.
37. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185 : 1693 1704. (Pubitemid 27203265)
38. Toffoli MC, Gabra BH, Teixeira CF, Sirois P, Jancar S (2007). Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment. Inflammation 30 : 28 37. (Pubitemid 46438045)
39. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D et al. (2004). Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63 : 31 35. (Pubitemid 38064600)
40. 4 receptor homologue gene. J Immunol 169 : 3363 3369. (Pubitemid 35013186)
41. Verri WA Jr., Guerrero AT, Fukada SY, Valerio DA, Cunha TM, Xu D et al. (2008). IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A 105 : 2723 2728. (Pubitemid 351520580)
42. Yacoubian S, Serhan CN (2007). New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol 3 : 570 579. (Pubitemid 47506014)
43. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M et al. (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61 : 119 161.
44. Zhang L, Zhang X, Wu P, Li H, Jin S, Zhou X et al. (2008). BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflamm Res 57 : 157 162. (Pubitemid 351601325)
45. Zouki C, Baron C, Fournier A, Filep JG (1999). Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol 127 : 969 979. (Pubitemid 29295357)